BCAL Diagnostics LimitedASX: BDX

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX · · 8 pages · English

Release

ASX Announcement 30 July 2026 Appendix 4C – June 2026 Quarterly Activities Report Highlights • Anne- Louise Arnett appointed Chief Executive Officer, effective 1 June 2026, bringing more than 25 years of medical technology commercialisation and operational leadership experience ...

BCAL Diagnostics Limited on 6ix

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases